Oppenheimer & Co. Inc. Purchases 179,763 Shares of FIGS, Inc. (NYSE:FIGS)

Oppenheimer & Co. Inc. increased its holdings in shares of FIGS, Inc. (NYSE:FIGS - Free Report) by 106.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 348,628 shares of the company's stock after acquiring an additional 179,763 shares during the quarter. Oppenheimer & Co. Inc. owned approximately 0.21% of FIGS worth $1,600,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of FIGS. Ameriprise Financial Inc. lifted its stake in FIGS by 37.9% in the fourth quarter. Ameriprise Financial Inc. now owns 12,188,166 shares of the company's stock valued at $75,445,000 after purchasing an additional 3,352,846 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of FIGS during the 4th quarter valued at $12,152,000. Bank of New York Mellon Corp grew its stake in shares of FIGS by 83.3% during the 4th quarter. Bank of New York Mellon Corp now owns 2,315,163 shares of the company's stock worth $14,331,000 after acquiring an additional 1,052,384 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of FIGS by 23.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,350,572 shares of the company's stock worth $26,931,000 after acquiring an additional 827,149 shares during the period. Finally, Bamco Inc. NY increased its holdings in FIGS by 2.7% in the 4th quarter. Bamco Inc. NY now owns 30,837,759 shares of the company's stock worth $190,886,000 after acquiring an additional 807,681 shares during the last quarter. Hedge funds and other institutional investors own 92.21% of the company's stock.

Analysts Set New Price Targets

FIGS has been the topic of several recent research reports. Morgan Stanley dropped their price objective on shares of FIGS from $4.75 to $4.25 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. The Goldman Sachs Group dropped their price target on shares of FIGS from $4.25 to $3.75 and set a "sell" rating on the stock in a research note on Tuesday, April 22nd. Barclays reaffirmed a "positive" rating on shares of FIGS in a report on Tuesday, May 13th. Finally, Telsey Advisory Group reissued a "market perform" rating and set a $5.00 target price on shares of FIGS in a report on Tuesday, May 13th.

FIGS Price Performance

Shares of FIGS traded up $0.03 during midday trading on Tuesday, hitting $5.67. 1,559,383 shares of the company traded hands, compared to its average volume of 2,670,753. FIGS, Inc. has a one year low of $3.57 and a one year high of $7.06. The firm has a market cap of $921.66 million, a P/E ratio of 567.57 and a beta of 1.32. The stock has a 50-day moving average of $4.81 and a 200-day moving average of $5.04.

FIGS Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.